Literature DB >> 12902036

Cooperative transformation of murine fibroblast NIH3T3 cells by hepatitis C virus core protein and hepatitis B virus X protein.

Eun Young Jung1, Hae Kyung Kang, Jun Chang, Dae-Yeul Yu, Kyung Lib Jang.   

Abstract

Co-infection with hepatitis B virus (HBV) and hepatitis C Virus (HCV) is associated with increased frequency in the development of hepatocellular carcinoma (HCC). Here, we demonstrated that HBV X protein (HBx) and HCV core cooperate to transform mouse fibroblast NIH3T3 cells. They additively stimulated cell growth, especially in the absence of serum growth factors. In addition, co-expression of HBx and HCV core had additive effects on the induction of anchorage-independent cell growth as well as on the secretion of matrix metalloproteases, which may contribute to increased metastatic potential. Furthermore, the cells expressing both viral proteins exhibited higher tumorigenicity, as demonstrated in athymic nude mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902036     DOI: 10.1016/s0168-1702(03)00135-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  3 in total

1.  Biological impact of hepatitis B virus X-hepatitis C virus core fusion gene on human hepatocytes.

Authors:  Zhen Ma; Qin-Hai Shen; Guo-Min Chen; Da-Zhi Zhang
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.

Authors:  Jian Guan; Xiao-Ping Chen; Hong Zhu; Shun-Feng Luo; Bin Cao; Lei Ding
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

3.  Interferon-α sensitizes HBx-expressing hepatocarcinoma cells to chemotherapeutic drugs through inhibition of HBx-mediated NF-κB activation.

Authors:  Yanning Liu; Guohua Lou; Wei Wu; Yu Shi; Min Zheng; Zhi Chen
Journal:  Virol J       Date:  2013-05-29       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.